Clinical Trial

DLL3-Targeted PET/CT in Small Cell Lung Cancer

Name: DLL3-Targeted PET/CT in Small Cell Lung Cancer — clinical trial record (NCT07677787)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of the study is to evaluate the diagnostic value of DLL3-targeted PET/CT in patients with suspected or histologically confirmed small cell lung cancer, and to compare with conventional imaging modalities.

Trial Details

NCT Number	NCT07677787
Lead Sponsor	The First Affiliated Hospital of Xiamen University
Conditions	PET/CT, Small Cell Lung Cancer ( SCLC ), DLL3-targeted PET/CT, Delta-like Protein 3
Enrollment	20 participants
Start Date	2026-05-09
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-01